The vector of anti-CD171 chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human CD171. The T cells are genetically modified through transduction with a lentiviral vector expressing scFv of anti-CD171 antibody linked to CD3-zeta signaling domains. And the vector product was designed for the treatment of metastatic neuroblastoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-2-M307-4G||Anti-CD171 scFv h(CD4-FcεRIγ) CART, pCDCAR1|
|CAR-T-2-M307-CZ||Anti-CD171 scFv h(b2c-CD3ζ) CART, pCDCAR1|
|CAR-MZ195||Anti-L1-CAM (CE7) h(CD3ζ) CAR, pCDCAR1|
|CAR-T-1-M307-G||Anti-CD171 scFv h(FcεRIγ) CART, pCDCAR1|
|VP-CAR-LC887||Lenti-L1 cell adhesion molecule(L1-CAM) CAR (scFv-41BB-CD3ζ, CE7) Viral Particle|
|CAR-T-1-M307-2||Anti-CD171 scFv h(CD28) CART, pCDCAR1|
|CAR-T-2-M307-BZ||Anti-CD171 scFv h(41BB-CD3ζ) CART, pCDCAR1|
|CAR-T-2-M307-4Z||Anti-CD171 scFv h(CD4-CD3ζ) CART, pCDCAR1|
|VP-CAR-LC309||Lenti-CD171 CAR (scFv-CD28-CD3ζ, CE7) Viral Particle|
|VP-CAR-LC306||Lenti-CD171 CAR (scFv-FcεRIγ, CE7) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved